Status:
COMPLETED
Open-Label Placebo Treatment for Acute Postoperative Pain
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Postoperative Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is to evaluate whether the amount of morphine intake in acute postoperative pain following minimally invasive Transforaminal Lumbar Interbody Fusion (TLIF) can be decreased with an Open-Lab...
Eligibility Criteria
Inclusion
- Signed Informed Consent
- Scheduled to receive a TLIF procedure at University Hospital Basel (USB)
- 18 years or older
- German speaking
- Able to understand the study and its outcome measures
Exclusion
- Known chronic pain, which is unrelated to problem targeted by the surgery
- Known neuromuscular disease
- Known mental disorders
- Known drug or massive alcohol intake or of other psychoactive substances
- Known kidney or liver disease (glomerular filtration rate (GFR)/ GFR \< 30)
- Contraindications to the class of drugs under investigation, e.g., known hypersensitivity or allergy to the investigational product
- Parallel participation in another study with investigational drugs
- More than 30 mg/day (equivalent dose of oral morphine) preoperative opioid consumption
Key Trial Info
Start Date :
May 12 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2023
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT04339023
Start Date
May 12 2020
End Date
January 31 2023
Last Update
August 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Basel, Department of Anesthesia
Basel, Switzerland, 4031